Adis Journals
Browse
Summary Slide.png (67.78 kB)

Quality-of-Life Comparison of Dapagliflozin Versus Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Randomized, Controlled Trial (J-BOND Study)

Download (67.78 kB)
media
posted on 2020-10-13, 15:49 authored by Hitoshi Ishii, Hiroki Nakajima, Nozomu Kamei, Tetsuji Niiya, Toru Hiyoshi, Yuko Hiramori, Shigeyuki Ohtsu, Takashi Noto, Dai Shimono

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Usage metrics

    Diabetes Therapy

    Categories

    Keywords

    DapagliflozinDipeptidyl peptidase-4 inhibitorQuality of LifeSodium–glucose cotransporter 2 inhibitorType 2 diabetes mellitus

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC